| # | Drug | Count |
|---|---|---|
| 0 | ALENDRONATE SODIUM | 43 |
| 1 | ENOXAPARIN SODIUM | 15 |
| 2 | BISOPROLOL FUMARATE | 14 |
| 3 | LEVOTHYROXINE SODIUM | 14 |
| 4 | SIMVASTATIN | 14 |
| 5 | AMLODIPINE | 13 |
| 6 | DABIGATRAN ETEXILATE | 13 |
| 7 | FEBUXOSTAT | 13 |
| 8 | FEBUXOSTAT TABLETS 40 MG | 13 |
| 9 | FEBUXOSTAT TABLETS 80 MG | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZOIN RESIN | 1 | 0.0769 |
| 1 | COBALT | 1 | 0.0256 |
| 2 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 9 | 0.0032 |
| 3 | TINIDAZOLE | 1 | 0.0023 |
| 4 | FEBUXOSTAT TABLETS 40 MG | 13 | 0.0012 |
| 5 | FEBUXOSTAT | 13 | 0.0008 |
| 6 | FLURBIPROFEN | 1 | 0.0007 |
| 7 | CALCITONIN SALMON | 2 | 0.0006 |
| 8 | DARUNAVIR ETHANOLATE AND COBICISTAT | 1 | 0.0006 |
| 9 | CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 20 |
| 1 | HMG-CoA Reductase Inhibitor [EPC] | 19 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 18 |
| 3 | Estrogen [EPC] | 15 |
| 4 | Benzodiazepine [EPC] | 14 |
| 5 | Xanthine Oxidase Inhibitor [EPC] | 14 |
| 6 | Angiotensin Converting Enzyme Inhibitor [EPC] | 13 |
| 7 | Calcium Channel Blocker [EPC] | 13 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 13 |
| 9 | Vitamin D [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin [EPC] | 2 | 0.0006 |
| 1 | Neurokinin 3 Receptor Antagonist [EPC] | 1 | 0.0004 |
| 2 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 3 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 4 | Cephalosporin Antibacterial [EPC] | 2 | 0.0002 |
| 5 | Vitamin D2 Analog [EPC] | 1 | 0.0001 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 7 | 0.0001 |
| 8 | Angiotensin Converting Enzyme Inhibitor [EPC] | 13 | 0.0001 |
| 9 | Recombinant Human Growth Hormone [EPC] | 2 | 0.0001 |